Currently out of the existing stock ratings of Jack Allen, 21 are a HOLD (29.17%), 51 are a BUY (70.83%).

Jack Allen

Work Performance Price Targets & Ratings Chart

Analyst Jack Allen, currently employed at BAIRD, carries an average stock price target met ratio of 40.98% that have a potential upside of 43.91% achieved within 74 days.

Jack Allen’s has documented 127 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ACLX, Arcellx at 23-Feb-2026.

Wall Street Analyst Jack Allen

Analyst best performing recommendations are on VOR (VOR BIOPHARMA).
The best stock recommendation documented was for VOR (VOR BIOPHARMA) at 6/26/2025. The price target of $20 was fulfilled within 1 day with a profit of $2.2 (12.36%) receiving and performance score of 123.6.

Average potential price target upside

of $11.15 (27%) on ACLX (ARCELLX).
of $7.2 (196.81%) on VOR (VOR BIOPHARMA).
of $2.44 (4.82%) on CRSP (CRISPR THERAPEUTICS AG).

ALLO Allogene Therapeutics CLLS Cellectis SA DBTX Decibel Therapeutics FATE Fate Therapeutics INKT Mink Therapeutics TIL Instil Bio TSHA Taysha Gene Therapies VOR Vor Biopharma VYGR Voyager Therapeutics FREQ Frequency Therapeutics ACLX Arcellx CRSP Crispr Therapeutics AG RCOR Renovacor NTLA Intellia Therapeutics BLUE Bluebird bio LCTX Lineage Cell Therapeutics RC Ready Capital Corp

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Biren Amin (PIPER SANDLER)